Overview
STAT3-related early-onset multisystem autoimmune disease is a rare genetic condition caused by gain-of-function mutations in the STAT3 gene. This means the STAT3 protein becomes overactive, which disrupts the normal balance of the immune system. Instead of only fighting infections, the immune system mistakenly attacks the body's own healthy tissues and organs. This can affect many parts of the body, including the blood, thyroid, gut, lungs, joints, and skin. Symptoms typically begin in infancy or early childhood and can include low blood cell counts (cytopenias), type 1 diabetes, thyroid disease, inflammatory bowel disease, short stature, and recurrent infections. Because the immune system is dysregulated, patients may develop multiple autoimmune conditions over time, and the disease can be unpredictable in its severity. Treatment focuses on controlling the overactive immune system using immunosuppressive medications. Some patients may benefit from targeted therapies that block specific immune pathways, such as JAK inhibitors. In severe cases, bone marrow transplant (hematopoietic stem cell transplantation) has been considered. Management requires a team of specialists because so many organ systems can be involved. Early diagnosis through genetic testing is important to guide treatment decisions and monitor for new complications.
Key symptoms:
Low blood cell counts (anemia, low platelets, low white blood cells)Enlarged lymph nodesEnlarged spleenType 1 diabetes developing very early in lifeThyroid problems (underactive or overactive thyroid)Inflammatory bowel disease (chronic diarrhea, bloody stools)Short stature or poor growthSkin rashes or eczema-like skin problemsJoint pain or swellingLung inflammation or interstitial lung diseaseRecurrent infectionsLiver inflammationDelayed pubertyFatigue and low energyCeliac-like gut disease
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for STAT3-related early-onset multisystem autoimmune disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for STAT3-related early-onset multisystem autoimmune disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for STAT3-related early-onset multisystem autoimmune disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to STAT3-related early-onset multisystem autoimmune disease.
Community
No community posts yet. Be the first to share your experience with STAT3-related early-onset multisystem autoimmune disease.
Start the conversation →Latest news about STAT3-related early-onset multisystem autoimmune disease
No recent news articles for STAT3-related early-onset multisystem autoimmune disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which organs are currently affected in my child, and how will you monitor for new complications?,Would a JAK inhibitor like ruxolitinib be appropriate for my child's case?,How often will my child need blood tests and specialist visits?,Is bone marrow transplant something we should consider, and what are the risks and benefits?,What signs of infection or other emergencies should I watch for at home?,Are there any clinical trials or new treatments being studied for this condition?,How can we support my child's growth, nutrition, and emotional well-being while managing this disease?
Common questions about STAT3-related early-onset multisystem autoimmune disease
What is STAT3-related early-onset multisystem autoimmune disease?
STAT3-related early-onset multisystem autoimmune disease is a rare genetic condition caused by gain-of-function mutations in the STAT3 gene. This means the STAT3 protein becomes overactive, which disrupts the normal balance of the immune system. Instead of only fighting infections, the immune system mistakenly attacks the body's own healthy tissues and organs. This can affect many parts of the body, including the blood, thyroid, gut, lungs, joints, and skin. Symptoms typically begin in infancy or early childhood and can include low blood cell counts (cytopenias), type 1 diabetes, thyroid dise
How is STAT3-related early-onset multisystem autoimmune disease inherited?
STAT3-related early-onset multisystem autoimmune disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does STAT3-related early-onset multisystem autoimmune disease typically begin?
Typical onset of STAT3-related early-onset multisystem autoimmune disease is infantile. Age of onset can vary across affected individuals.